Corgi U.S. Equities 100% Structured Buffer ETF - July Series (HJLY)

On our desk, liquidity is always the primary filter before we allocate capital. Looking at HJLY, seeing daily volume bounce between 6 and roughly 1,900 shares with an AUM hovering around $1.4 million tells me this fund is still in its infancy following its July 2026 inception. While the 100% downside cushion on SPY sounds appealing for risk-averse accounts, the thin trading volume creates noticeable execution risks with bid-ask spreads. Until market makers build deeper liquidity and assets scale up significantly, we are advising clients to watch from the sidelines rather than dive in.

Analyzing the product structure from a quantitative risk perspective, HJLY relies entirely on FLEX options linked to the SPDR SandP 500 ETF Trust (SPY) to engineer its 100% buffer. The trade-off is mathematically rigid: you trade away all upside beyond a stated cap in exchange for complete loss absorption over the annual outcome period running from July 2026 to June 2027. With an expense ratio reported between 0.30% and 0.40%, the drag is modest, but investors must calculate whether sacrificing uncapped market participation makes sense during a period where the fund's YTD performance sits at a muted +1.14%.

As a clinical portfolio strategist evaluating structured products for conservative patient-endowments, my main protocol involves verifying the exact reset dates and option expiration dynamics. HJLY resets annually every July, meaning the current outcome period locks in values through June 30, 2027. If an investor enters mid-cycle, their effective cap and buffer profile shifts relative to the initial fund NAV of around $25.41. When discussing this with trustees, we emphasize that the 100% protection is calculated before fees and expenses, and only applies if held for the full duration of the annual outcome period.